Clinical Trial Update: A Programme for Amyotrophic Lateral Sclerosis Care in Europe

View source ↗

Summary

This document reports an ongoing European program designed to improve care for people with amyotrophic lateral sclerosis (ALS) and motor neuron disease (MND).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Amyotrophic Lateral Sclerosis
• Motor Neuron Disease

Snippet

Sponsor: Sheffield Teaching Hospitals NHS Foundation Trust | Conditions: ALS (Amyotrophic Lateral Sclerosis), MND (Motor Neurone DIsease) | Status: UNKNOWN